Upcoming Events
Search Result For "Antibodydrugconjugate".
- Event Type
- Event Category
- Event Country
- Event Date
Event Type
Categories
Country
City
Date
The 5th World ADC Summit South Korea (9-11 June 2026 | Seoul) is Asia's premier meeting dedicated to accelerating next-generation antibody drug ...
With numerous novel conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and m...
The 13th World ADC London returns in 2023 as Europe's longest standing and definitive antibody-drug conjugate event - and it's back bigger and bett...
As the proportion of clinically site-specific ADCs increases, the abundance of novel conjugation technologies diversifies, and the linker chemistry...
The ADC renaissance has continued to dominate the oncology field throughout 2023, with the long-awaited approval of ImmunoGen's ELAHERE - the 9th A...
Antibody-drug conjugates are coming of age with a remarkable surge in recent times, which has marked a turning point in their development. Notable ...
As ADCs as a modality see continued clinical progress, drug developers are becoming more creative with their drug design and new analytical technol...
Antibody-drug conjugates (ADCs) have emerged as a rapidly evolving, highly promising class of oncology drugs, with 12 approvals and many more in de...
Welcome to the 4th ADC Target Selection Summit! Get the First Most Important Decision Right. The ADC field continues to grow, saturating the ind...
As ADC approvals grow and pipelines expand, dose selection has become one of the field’s biggest challenges, and Project Optimus has resul...
Loading More...
